Advaita Bio Molecules Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 3 Days
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 5.13%
- Profit Growth 88.77%
- Ebitda 132.71%
- Net Worth -7.66%
- Total Assets 22.50%
About Advaita Bio Molecules
Advaita Bio Molecules Private Limited (ABMPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 February 2019 (Six years 3 days old ). Its registered office is in Krishna, Andhra Pradesh, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Gangarapu Naidu and Chandrasekar Mandum serve as directors at the Company.
Company Details
-
Location
Krishna, Andhra Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24299AP2019PTC111159
-
Company No.
111159
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Feb 2019
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Vijayawada
Industry
Who are the key members and board of directors at Advaita Bio Molecules?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gangarapu Naidu
|
Director | 12-Feb-2019 | Current |
|
Chandrasekar Mandum
|
Director | 02-Feb-2022 | Current |
Financial Performance of Advaita Bio Molecules.
Advaita Bio Molecules Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 5.13% increase. The company also saw a substantial improvement in profitability, with a 88.77% increase in profit. The company's net worth dipped by a decrease of 7.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Advaita Bio Molecules?
In 2023, Advaita Bio Molecules had a promoter holding of 99.00% and a public holding of 1.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Siri Geosolutions Private LimitedChandrasekar Mandum is a mutual person
-
Advaita Minechem Private LimitedGangarapu Naidu is a mutual person
-
Advaita Global Exim Private Limited
Gangarapu Naidu is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Advaita Bio Molecules?
Unlock and access historical data on people associated with Advaita Bio Molecules, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Advaita Bio Molecules, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Advaita Bio Molecules's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
